INTRODUCTION
Patient-reported outcomes (PROs) are an essential evaluative tool in clinical research and practice. In oncology, survival rates have steadily improved while treatment options have increased dramatically. Therefore, other health endpoints and treatment costs have taken on unprecedented importance, as value-based cancer care. New treatment options must directly consider impact on symptoms, functioning, and general perceptions of health and well-being. 1 the same metric. However, to our knowledge, no study to date has linked a disease-specific measure with the common metric. We hypothesized that disease-specific measures related to physical function can be linked to the broader PROMIS PF metric, but that adaptations will be necessary for optimal results. Specifically, the Functional Assessment of Cancer Therapy (FACT) Physical WellBeing (PWB) 7-item subscale overlaps with PROMIS PF item bank content, but also includes questions regarding treatment-related symptoms that are conceptually distinct from the PROMIS definition of PF. The purpose of the current study was to evaluate the extent to which the cancer-specific FACT-General (FACT-G) PWB subscale could be linked with the PROMIS PF metric. [6] [7] [8] We hypothesized that the optimal link would include a subset of FACT-G PWB items and that the link would be improved by augmenting the most conceptually similar items with PROMIS PF items. The core FACT-G questionnaire has been used to measure health-related quality of life in oncology patients for 25 years. 9 Although it originally was developed for patients with cancer, the FACT-G has been used in other chronic conditions, 10 and norms have been developed for the general population. Given its widespread use in oncology, it is a prime candidate for examining disease-specific to domain-general linking.
MATERIALS AND METHODS

Participants
Participants were drawn from the Measuring Your Health (MY-Health) study, a prospective cohort study that measured the health and well-being of adult patients with cancer. Linking was conducted using the baseline data set (5506 participants). The link then was cross-validated among follow-up patients (2957 patients). Baseline occurred 6 to 13 months after diagnosis, and follow-up was 6 months after baseline. Participants in the MYHealth study were recruited through 4 Surveillance, Epidemiology, and End Results registries in 3 states between 2011 and 2013. Individuals were eligible to participate if they were an adult diagnosed with 1 of 7 types of cancer (breast cancer, prostate cancer, colorectal cancer, nonsmall cell lung cancer, non-Hodgkin lymphoma, uterine cancer, or cervical cancer). Racial and ethnic minorities and younger individuals with a cancer diagnosis were oversampled. At baseline, approximately 36% of eligible respondents completed and returned the measures. Of those, 54% completed follow-up assessments. Further study design details and participant descriptions can be found elsewhere.
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Measures
The FACT-G is a 27-item questionnaire measuring 4 domains: Physical, Social/Family, Emotional, and Functional Well-Being. 9 It also gives a total score. This study used the FACT-G PWB subscale, which comprised 7 items rated on a 5-point Likert scale from 0 to 4. Items are reverse-scored and summed (range, 0-28), with higher scores indicating better well-being.
PROMIS PF is one of the original PROMIS item banks. 3, 5 Items are rated on a 5-point Likert scale from 1 to 5 and responses are scored using expected a posteriori (EAP) estimation 12 and then transformed onto the Tscore metric. For practical purposes, scores in the PROMIS PF item bank range from approximately 10 to 75, representing significant impairments to above-average functioning. For the MY-Health study, a 16-item custom short form was used from the full item bank. 13 This custom short form is a combination of the Physical Function Short Form 6a and the Physical Function Short Form 10a
5 "off-the-shelf" short forms, which allow for smaller standard errors for score estimates and a wider range of scores than either short form allows alone.
Study Design
A hybrid nonequivalent anchor test (NEAT) linking design, also referred to as linking to a calibrated item pool, was used to link the FACT-G PWB with the PROMIS PF metric. 7 Some analyses differed between this task and previous PROsetta Stone studies. 8, 14, 15 The anchor in a hybrid-NEAT design is both a "full" measure (ie, custom short form) and a subset of the full item bank. The known PROMIS item calibrations (and resulting individual-level scores) are used. The hybrid-NEAT design treated FACT-G PWB items as if they were candidate PROMIS items, placing them on the PROMIS T-score metric. They then can be rescored onto the PROMIS metric, as if they were a custom short form from the calibrated item bank.
Linking was conducted using the MY-Health baseline data and cross-validated in the follow-up data. Pattern scores were calculated by linking all 7 FACT-G PWB items, a 5-item subset (excluding [abbreviated] items "nausea" and "bothered by side effects"), and the 2-item FACT-G PWB subset with items most closely reflecting PROMIS PF (including only "trouble meeting the needs of my family" and "spend time in bed"). The 3 competing item subsets were compared, which allowed us to examine the potential effects of disease-specific items on a domaingeneral metric.
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Statistical Analysis
Graphical and statistical procedures were used to determine the optimal FACT-G PWB item subset. Descriptive statistics were calculated for the PROMIS PF and linked FACT-G PWB T-scores, the differences between them, and the root mean squared difference. Finally, BlandAltman plots were produced to examine the limits of agreement between the linked and actual scores. 16 Because there are content differences between disease-specific measures such as the FACT-G PWB and domain-general metrics such as PROMIS PF, we also sought to examine whether augmenting the most relevant content from the FACT-G PWB with a small number of PROMIS PF items would reduce linked score bias, minimize floor and ceiling effects, and improve the link overall. Although augmenting the FACT-G may not benefit existing data, it will support ongoing and future data collection waves. We then would recommend that these PROMIS PF items be coadministered along with the FACT-G PWB in future studies. Qualitatively, we limited potential items for augmenting to those in the PROMIS PF Cancer item bank, 17, 18 those that were administered in the MY-Health study, and those that were included on existing PROMIS PF short forms. Items meeting these criteria were reviewed for nonoverlapping content well representing the PROMIS PF item bank. For psychometric reasons, we also required that the candidate items have high item information curves across a range of scores. The final consideration in item determination was respondent burden.
The final step was to determine how well this FACT/PROMIS measure recovered individual-level scores on the PROMIS PF metric. This evaluation involved procedures identical to those used in determining the optimal FACT-G PWB item subset. Given that the augmenting items also were included in the PROMIS score calculation, "unadjusted" and "adjusted" PROMIS scores were calculated by including or removing the overlapping items, respectively, from the EAP score calculation.
RESULTS
Linking FACT-G PWB and PROMIS PF
To properly link instruments, they should measure nearly the same concept and be essentially unidimensional. 19 For this purpose, we conducted exploratory bifactor analyses on the aggregated item subsets, correlated scores, calculated Cronbach alphas, and fit a unidimensional IRT model. Results from this assumption-checking step are shown in Table 1 . The high interscale correlations, and the alpha and omega hierarchical values, were within the recommended ranges. 8, 20 Together these indices suggest that the aggregated scales are broadly unidimensional, and that the 5-item subset may be statistically optimal for linking. Table 2 summarizes the agreement and differences between the competing linking relationships. The mean difference, standard deviation of differences, and root mean squared difference should be minimized, whereas the correlation between scores should be maximized. Bias (mean difference) was greatest for the 2-item link, followed by the 7-item link. Again, the 5-item link was optimal. The Bland-Altman plot representing this relationship is provided in Figure 1 . The red line indicates the ideal, or unbiased, difference, whereas the black line shows the obtained mean difference. The dashed gray lines are the 95% limits of agreement, which suggest a high degree of uncertainty at the individual level. The dotted blue line is a loess line, which suggests that bias was negligible for individuals with impaired functioning, but 
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Cancer January 1, 2018 that the linked scores overestimate low-average functioning and underestimate (due to the difference in form ceilings) high-average functioning. Parameter estimates for all 3 competing item subsets are available in Supporting Information Material A.
Augmenting FACT-G PWB With PROMIS PF
The 2-item subset from the FACT-G PWB has the most relevant content to the PROMIS PF item bank, but was not optimal for linking. Therefore, for future applications, we aimed to augment this subset with items from the PROMIS PF bank. Three items were suggested: PFA11 ([abridged] "chores such as vacuuming or yard work"), PFA53 ("run errands and shop"), and PFA1 ("[limited] in doing vigorous activities"). These items, together with the FACT-G PWB 2-item subset, were chosen for an augmented FACT/PROMIS-PF5 form. Tables 1 and 2 provide descriptive statistics regarding the accuracy of the FACT/PROMIS-PF5 in recovering PROMIS PF scores. The unadjusted score used all 16 PROMIS PF items from the MY-Health study, whereas the adjusted scores contained only the 13 nonoverlapping items. As suspected, augmented scores provided a significant improvement over linking with the FACT-G PWB. Correlations were higher, bias was reduced further, and the variance of differences between actual and augmented scores was smaller. Figure 2 graphically confirms this improvement of the augmented FACT/PROMIS-PF5 over the FACT-G PWB 5-item subset. The axes were set identical to Figure  1 for the purpose of comparison. As is evident, the mean difference was significantly closer to the ideal difference, the loess line was flatter across the score range, and the limits of agreement were tighter, suggesting a significantly improved score recovery expectation on an individual level. Nonetheless, the FACT/PROMIS-PF5 scores have both floor and ceiling effects, which are similar to the existing PROMIS short forms. Supporting Information Material B provides a table showing the conversion from raw score to T-score for scoring the FACT/PROMIS-PF5.
DISCUSSION
To the best of our knowledge, the current study is the first to link a disease-specific physical well-being measure with a general physical function domain metric. It also is the first illustration of the use of an IRT-calibrated PROMIS item bank to augment common, widely used oncology questionnaires. We expected that some physical wellbeing items relevant in cancer and captured by the FACT-G PWB would not be related to the more general PROMIS domain. This was confirmed; attempting to link the full 7-item FACT-G PWB had suboptimal linked score precision. Consistent with our hypotheses, although the 2-item FACT-G PWB had content best reflective of PROMIS PF, it also was not optimal for linking. The 5-item subset included additional items less strongly related to how the PROMIS metric defines physical functioning, but the additional content allowed adequate score representation across a broader range.
Calibrating the FACT-G PWB items to the PROMIS PF item bank provided the opportunity to create a custom short form by blending items from the 2 measures. To our knowledge, this is the first study to attempt to augment an existing health-related measure with items from a linked metric. The PROMIS PF item bank was qualitatively and quantitatively reviewed for the potential to augment the 2 conceptually similar FACT-G PWB items. Three PROMIS PF items were identified that had good psychometric properties, addressed unique aspects of physical functioning, and covered the broadest score range. Together, we refer to these 5 items as the FACT/PROMIS-PF5. This 5-item form wellapproximated the actual PROMIS PF scores, even after correcting for the overlapping items.
Intended Use for Linked and Augmented Scores
Consistent with recommendations in previous linking studies, 6, 8 using linked scores from the FACT-G PWB to PROMIS PF is most appropriate with existing grouplevel data, and caution must be exercised whenever considering the use of linked scores at an individual level. Although using the 5-item FACT-G PWB subset minimized linking bias, individual-level scores were found to demonstrate wide variability.
Given the high similarity and reduced variability between the FACT/PROMIS-PF5 and actual PROMIS PF scores, they can be recommended for both individuallevel and group-level analyses. The FACT/PROMIS-PF5 holds significant potential for improving clinical and research endeavors, especially within populations of patients with cancer. By adding only a few PROMIS PF items to the FACT-G, a researcher has the interpretability of the PROMIS metric and FACT-based cancer reference values. However, beyond individual-level or group-level distinctions for analyses, there are other intended uses for the 2 types of scores. Both types are useful for data aggregation. Linked scores will have the greatest applicability for data aggregation of existing information. The majority of existing data will not have both of the measures. This aggregation can rely on the 5-item FACT-G PWB subset to obtain linked scores. From a practical perspective, this would require that existing data were recorded at an item level as opposed to a subscale score level, which may be a limitation for some researchers. The FACT/PROMIS-PF5 will find greater use in new prospective data collection. Researchers and clinicians do not need to move away from the FACT measurement system to PROMIS, but rather can add the recommended 3 items with relatively minimal effect on respondent burden.
These linked or augmented scores are not meant to suggest the superiority of one measurement system over another. FACT and PROMIS have unique measurement strengths and weaknesses. FACT-G is a multidimensional health-related quality-of-life questionnaire developed for individuals with cancer. Additional subscales and modules are available for specific types of cancer. FACT has been expanded to include other chronic illnesses, again with disease-specific modules intended to enhance the general measure. PROMIS domains such as PF were designed to be universally relevant (ie, not disease specific). Rescoring the FACT-G PWB onto the PROMIS PF metric does not suggest that one is preferred over the other but rather that they can be treated as interchangeable, at least with respect to the physical function component. Indeed, linking should be a symmetrical relationship, 7 and by using the suggested test characteristic curve, a PROMIS PF T-score could be converted into a FACT-G PWB sum score.
Obtaining Linked or Augmented Scores
The result of most PROMIS linking studies is a crosswalk table between a raw sum score on the "legacy" measure and the relevant PROMIS metric (see Supporting Information Material B). 6 These tables used the Lord and Wingersky algorithm to estimate conversions from sum score to EAP score 21 for the 5-item subset from the FACT-G or the augmented FACT/PROMIS-PF5. Care must be used to ensure appropriate item selection and response option indexing.
As an alternative, and to use pattern-based responding, we have created a scoring script for R 22 (available on www.prosettastone.org) to estimate these scores. This script uses the rpf package 23 to calculate EAP scores and transform them onto the PROMIS PF metric. Users provide item-level data with FACT-G PWB and the 3 PROMIS PF items (if calculating augmented scores) with the item names as column headers. Scores are estimated for each individual. More information is provided with the R script to improve accessibility of both the linked and augmented scores.
Limitations and Future Directions
Although the current study has many strengths, some limitations should be noted. First, the correlation between the FACT-G PWB and PROMIS PF was lower than optimal. Generally, a correlation > 0.80 is recommended for linking. In cases in which the scales are broadly unidimensional but some multidimensional aspects may exist, alternative linking procedures have been suggested (eg, equipercentile 24 or calibrated projection 25 . These concerns are not relevant to the augmented scores, but perhaps the linked scores could have been improved were an alternative method also considered.
Because the PROMIS PF item calibrations were used as the basis for linking, the FACT/PROMIS-PF5 should be viewed as a PROMIS custom short form; it does not provide a FACT score beyond the original 7-item FACT-G PWB. To the extent that the underlying construct has changed in the process, the augmented score reflects more physical function as measured by PROMIS than physical well-being as measured by FACT-G. Although common in educational testing, 26 augmenting existing measures is rare in health outcome measurement. We suggest that more of this type of activity should occur in health measurement, as a natural byproduct of an IRTcalibrated item pool and the ability to create custom short forms from that pool. This may be the most effective means by which disease-specific and domain-general measures can be combined on a common metric.
One final limitation of the current study also relates to the ceiling effects of the FACT/PROMIS-PF5 in this sample. At baseline, 0.8% and 13.5%, respectively, of the sample were on the floor or ceiling. At follow-up, these values were 0.5% and 19.6%, respectively. The observed ceiling effects could be mitigated further with the addition of "high-functioning" items. We note that the majority of physical functioning scales currently in use have similar ceiling effects, suggesting that this is an issue for all brief measures of physical function, including PROMIS PF short forms. 27, 28 However, the PROMIS PF computerized adaptive testing extends this ceiling beyond other commonly used short forms. 5 The strengths of the PROMIS and FACT measurement systems complement each other. PROMIS allows for comparisons with the general population. However, the FACT measurement system allows subscales for disease-specific concerns for various cancer diagnoses and chronic illnesses. One criticism of PROMIS is that, by Original Article design, it is "generic" and thus does not address important concepts for specific diseases such as cancer. Using FACT subscales in the relevant disorders alongside PROMIS domains supports outcomes assessments as needed. Researchers and clinicians can use the augmented FACT/ PROMIS-PF5 while being assured of accurate score estimation for PROMIS, consistent with recent guidance from the US Food and Drug Administration, and maintain comparability with existing FACT-G studies, including the ability to add disease-specific modules without compounding respondent burden. Future linking studies should further examine whether item subsets are necessary when linking other disease-specific measures, and if augmenting those subsets also improves the relationship between measures. The methods used herein can be generalized to future efforts.
The FACT-G PWB now can be rescored onto the PROMIS metric using either the linked or augmented scores reported herein. Existing group-level data can be linked using a 5-item subset, whereas future studies should add 3 items from PROMIS PF to the FACT-G, making it a 30-item questionnaire. This will support future data aggregation efforts and comparability of the results to both existing and future PROs in oncology.
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